Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Rudwaleit

Showing results (121-130 of 150) with videos related to

Pageof 15
Sort By:
RMD Open|November 28, 2025
Sustained improvements in spinal pain, morning stiffness, fatigue, sleep, physical function and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: 2-year results from two phase 3 studiesHelena Marzo-Ortega, Victoria Navarro-Compan, Maureen Dubreuil, et al.
The Journal of Rheumatology|October 15, 2024
Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE StudiesVictoria Navarro-Compán, Martin Rudwaleit, Maureen Dubreuil, et al.
Annals of the Rheumatic Diseases|August 1, 2019
Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohortsAnne Boel, Anna Molto, Désirée van der Heijde, et al.
The Journal of Rheumatology|April 5, 2007
Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experimentCédric Lukas, Jürgen Braun, Désirée van der Heijde, et al.
The Journal of Rheumatology|April 5, 2007
Is there a preferred method for scoring activity of the spine by magnetic resonance imaging in ankylosing spondylitis?Désirée van der Heijde, Robert Landewé, Kay-Geert Hermann, et al.
Annals of the Rheumatic Diseases|July 8, 2024
Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trialsMatthew A Brown, Martin Rudwaleit, Floris A van Gaalen, et al.
Annals of the Rheumatic Diseases|May 24, 2022
MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working groupXenofon Baraliakos, Mikkel Østergaard, Robert Gw Lambert, et al.
Rheumatology (Oxford, England)|February 1, 2021
Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utilityWalter P Maksymowych, Robert G Lambert, Xenofon Baraliakos, et al.
Arthritis Research & Therapy|April 9, 2021
Deep learning for detection of radiographic sacroiliitis: achieving expert-level performanceKeno K Bressem, Janis L Vahldiek, Lisa Adams, et al.
Rheumatology (Oxford, England)|May 13, 2017
Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpADésirée van der Heijde, Maxime Dougados, Robert Landewé, et al.
Pageof 15

Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
RMD Open|November 28, 2025
Sustained improvements in spinal pain, morning stiffness, fatigue, sleep, physical function and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: 2-year results from two phase 3 studiesHelena Marzo-Ortega, Victoria Navarro-Compan, Maureen Dubreuil, et al.
The Journal of Rheumatology|October 15, 2024
Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE StudiesVictoria Navarro-Compán, Martin Rudwaleit, Maureen Dubreuil, et al.
Annals of the Rheumatic Diseases|August 1, 2019
Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohortsAnne Boel, Anna Molto, Désirée van der Heijde, et al.
The Journal of Rheumatology|April 5, 2007
Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experimentCédric Lukas, Jürgen Braun, Désirée van der Heijde, et al.
The Journal of Rheumatology|April 5, 2007
Is there a preferred method for scoring activity of the spine by magnetic resonance imaging in ankylosing spondylitis?Désirée van der Heijde, Robert Landewé, Kay-Geert Hermann, et al.
Annals of the Rheumatic Diseases|July 8, 2024
Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trialsMatthew A Brown, Martin Rudwaleit, Floris A van Gaalen, et al.
Annals of the Rheumatic Diseases|May 24, 2022
MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working groupXenofon Baraliakos, Mikkel Østergaard, Robert Gw Lambert, et al.
Rheumatology (Oxford, England)|February 1, 2021
Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utilityWalter P Maksymowych, Robert G Lambert, Xenofon Baraliakos, et al.
Arthritis Research & Therapy|April 9, 2021
Deep learning for detection of radiographic sacroiliitis: achieving expert-level performanceKeno K Bressem, Janis L Vahldiek, Lisa Adams, et al.
Rheumatology (Oxford, England)|May 13, 2017
Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpADésirée van der Heijde, Maxime Dougados, Robert Landewé, et al.
Pageof 15